Molecular Disease Diagnostics Articles & Analysis
14 articles found
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. This significant advancement represents a vital leap in the quest for more precise and effective treatments for ovarian cancer. With the complexities of ovarian cancer treatment becoming ...
Enhancing the stability, specificity, and activity of these enzymes under various conditions could expand their application in synthetic biology, molecular diagnostics, and gene editing technologies. Structural biology techniques, such as X-ray crystallography and cryo-electron microscopy, are providing unprecedented insights into RNase function and guiding the ...
Research has found that nanobodies can effectively penetrate the blood-brain barrier and enter the brain to treat brain diseases. Generally, the immunogenicity of the antibody is related to the molecular size, that is, the smaller the molecular weight, the smaller the immunogenicity of the antibody. ...
What are rare diseases? Rare diseases are a diverse group of disorders that affect a small percentage of the population, often occurring as a result of genetic mutations. ...
Introduction to Quantitative Polymerase Chain Reaction A highly delicate technique for the amplification and identification of deoxyribonucleic acid is polymerase chain reaction (PCR). In molecular biology, its conceptual simplification has made it the most utilized method and can, in theory, identify as little as a single segment of DNA. Therefore, for a huge variety of bacterial, fungal, viral, ...
On the other hand, other tumor markers are predominantly produced in stage III and IV tumors, and they have little significance in early screening. Tumor molecular diagnostic reagents are primarily used for detecting gene mutation sites, which can be measured when there is a variation in tumor cells. ...
Every year, the 24th of March is recognized as World Tuberculosis Day to educate people around the world about the impact of the disease. Tuberculosis is a disease caused by Mycobacterium Tuberculosis, an airborne pathogen that mostly affects the lungs but can also attack other parts of the human body such as the kidneys, brain, and spine. It can affect people ...
The use of tumour markers to diagnose, assess prognosis, and select a suitable cancer treatment has become possible due to the development of inexpensive and user-friendly molecular analysis tools such as the polymerase chain reaction (PCR). Maintaining the integrity of biomarkers during their processing and storage is therefore of critical importance to accurately diagnose and give prognosis ...
It means we can now go after goals like therapeutic monoclonal antibodies for immunology, oncology and rare diseases. Many treatments for those conditions require higher doses of medication, which we can now achieve,” said Talat Imran, CEO of Rani, in an interview with BioSpace. ...
Introducing Beacon Biosignals: a neurotechnology company founded to develop machine learning-enabled EEG neurobiomarkers and accelerate precision medicine for any disease state affecting the brain Founded by MD/PhDs and engineers from Harvard and MIT, Beacon is propelled by the vision of a computing platform designed to scale the interrogation of large brain datasets with ...
Mic qpcr cycler and Myra liquid handler have been put through their paces in COVID-19-testing field trials in regional Western Australia and found to be noticeably robust, rapidly deployable and flexible. These results have been outlined in a recent paper, Development, deployment and in-field demonstration of mobile corona virus SARS-CoV-2 Nucleic acid amplification test, published by Paton, ...
Developing and manufacturing molecular diagnostics platforms and test kits for detecting human pathogens. Specializing in Antimicrobial Resistance Management and Hospital Associated Infections (HAIs), by reliable, cost-effective molecular diagnostic solutions for detecting Gastrointestinal Infections including most clinically relevant bacteria, parasites, viruses and antibiotic resistances. ...
1. INTRODUCTION Strategically eliminating damage caused by fungus requires precise identification of the fungal species present (using either conventional or molecular diagnostic techniques). The first step in performing molecular diagnostics on wood-decay fungi is to obtain analyzable fungal DNA. Five commercially available kits and one CTAB method were tested and analyzed in order to ...
